Quality Considerations for Topical Ophthalmic Drug Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 27, 2023
December 28, 2023
19494a43-f26e-42c9-b1ad-99a1126b3d42
Related Documents
Establishing Impurity Specifications for Antibiotics
Guidance DocumentApril 20, 2026Center for Drug Evaluation and Research
Clinical Pharmacology Considerations for Peptide Drug Products
Guidance DocumentDecember 14, 2023Center for Drug Evaluation and Research
Topical Dermatologic Corticosteroids: In Vivo Bioequivalence
Guidance DocumentOctober 24, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.